nach oben

Drug Safety

Erschienen in:

01.03.2010 | Original Research Article

The Relationship Between Study Characteristics and the Prevalence of Medication-Related Hospitalizations

A Literature Review and Novel Analysis

verfasst von: Anne J. Leendertse, Djurre Visser, Antoine C.G. Egberts, Dr Patricia M.L.A. van den Bemt

Erschienen in: Drug Safety | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background: Studies on medication-related hospitalizations differ in study setting, studied population, outcome, and method of data collection. Thus, extrapolations based on a meta-analysis of unselected studies may be biased.

Objective: To explore the influence of study characteristics on the prevalence of medication-related hospitalizations.

Methods: After a structured literature search, the retrieved studies were categorized based on the following aspects: (i) study setting (e.g. all hospital admissions vs only acute hospital admissions); (ii) study population (e.g. an entire hospital, study ward(s), selected population and/or age group); (iii) outcome of medication-related problem (e.g. adverse drug reaction [ADR] vs adverse drug event [ADE]); (iv) method of data collection (e.g. medical chart review, spontaneous reporting or database research); and (v) continent in which the study took place (only for studies looking at all acute admissions). We then examined the relationship between these factors and reported prevalence of medication-related hospital admissions.

Results: Ninety-five studies were analysed, with a range of reported prevalence of medication-related hospitalizations from 0.1% to 54%. Higher prevalences were found in the studies examining all hospital admissions than in the studies examining only acute hospital admissions. In addition, higher prevalences were found in the elderly population than in children. As would be expected, higher prevalences were also found in studies examining ADEs than in studies examining only ADRs. With respect to the method of data collection, medical chart screening resulted in higher prevalences of medication-related hospitalizations than database methods or spontaneous reporting. Combined studies in Europe show lower prevalences of medication-related hospital admissions than in other continents included in the study.

Discussion: The reported prevalence of medication-related hospital admissions varies as a function of the setting (all admissions or only acute admissions), studied population (entire hospital, specific wards, selected population and age group), outcome (ADR/ADE), the method of data collection and the continent in which the study is performed.

Conclusion: Extrapolation using national hospital admission data and the prevalence identified by pooling international studies should be carried out with great caution.

Nur mit Berechtigung zugänglich

Kohn L, Corrigan J, Donaldson M. To err is human: building a safer health system. Committee on Quality of Health Care in America, Institute of Medicine. Washington, DC: National Academy Press, 1999

Beijer JHM, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46–54PubMedCrossRef

Van der Hooft CS, Sturkenboom MCJM, Van Grootheest K, et al. Adverse drug reaction-related hospitalisations: a nationwide study in the Netherlands. Drug Saf 2006; 29: 161–8PubMedCrossRef

Van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 2008 Apr; 17: 365–71PubMedCrossRef

Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008 Sep 22; 168: 1890–6PubMedCrossRef

Ferner RE, Aronson JK. Clarification of terminology in medication errors: definitions and classification. Drug Saf 2006; 29: 1011–22PubMedCrossRef

Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9PubMedCrossRef

Deeks JJ, Higgins JPT, Altman DG, editors. Analysing and presenting results. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]. Chichester: John Wiley & Sons Ltd, 2005

Miller RR. Hospital admissions due to adverse drug reactions: a report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 1974; 134: 219–23PubMedCrossRef

10.

Levy M, Kewitz H, Altwein W, et al. Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol 1980; 17: 25–31PubMedCrossRef

11.

Larmour I, Dolphin RG, Baxter H, et al. A prospective study of hospital admissions due to drug reactions. Aust J Hosp Pharm 1991; 2: 90–5

12.

Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962–8PubMedCrossRef

13.

Classen DC, Pestotnik SL, Scott Evans R, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847–51PubMedCrossRef

14.

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital: their severity and cost involved. Pharmacoepidemiol Drug Saf 2003; 12: 687–92PubMedCrossRef

15.

Ibanez L, Laporte JR, Carne X. Adverse drug reactions leading to hospital admission. Drug Saf 1991; 6: 450–9PubMedCrossRef

16.

Smith JW, Seidl LG, Cluff LE. Studies on the epidemiology of adverse drug reactions: V. Clinical factors influencing susceptibility. Ann Intern Med 1966; 65: 629–40PubMedCrossRef

17.

Sidel VW, Koch-Weser J, Barnett GO, et al. Drug utilization and adverse reactions in a general hospital. Hospitals 1967; 41: 80–8PubMed

18.

Caranasos GJ, Steart RB, Cluff LE. Drug-induced illness leading to hospitalisation. JAMA 1974; 228: 713–7PubMedCrossRef

19.

Cooke DI, van der Merwe W, Pudifin DJ. Hospital admissions for adverse reactions to drugs and deliberate selfpoisoning. S Afr Med J 1985; 67: 770–2PubMed

20.

Lin SH, Lin MS. A survey on drug-related hospitalisation in a community teaching hospital. Int J Clin Pharmacol Ther Toxicol 1993; 31: 66–9PubMed

21.

Huic M, Mucolic V, Vrhovac B, et al. Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol Ther 1994; 32: 675–82PubMed

22.

Moore N, Lecointre D, Noblet C, et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301–8PubMedCrossRef

23.

Pouyanne P, Haramburu F, Imbs JL, et al. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ 2000; 320: 1036PubMedCrossRef

24.

Mannesse CK, Derkx FH, de Ridder MA, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35–9PubMedCrossRef

25.

Fattinger K, Roos M, Vergères P, et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 2000; 49: 158–67PubMedCrossRef

26.

Mjörndal T, Boman MD, Hägg S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002; 11: 65–72PubMedCrossRef

27.

Schneeweiss S, Hasford J, Göttler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285–91PubMedCrossRef

28.

Von Euler M, Eliasson E, O:hlén G, et al. Adverse drug reactions causing hospitalisation can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf 2006; 15: 179–84CrossRef

29.

Davidsen F, Haghfelt T, Gram LF, et al. Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol 1988; 34: 83–6PubMedCrossRef

30.

McKenzie MW, Stewart RB, Weiss CF, et al. A pharmacist based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973; 30: 898–903PubMed

31.

Mitchel AA, Lacouture PG, Sheehan JE, et al. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988; 82: 24–9

32.

Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol 1996; 42: 319–24PubMedCrossRef

33.

Jonville-Béra AP, Giradeau B, Blanc P, et al. Frequency of adverse drug reactions in children: a prospective study. Br J Clin Pharmacol 2002; 53: 207–10PubMedCrossRef

34.

Lamabadusuriya SP, Athiada G. Adverse drug reactions in children requiring hospital admission. Ceylon Med J 2003; 48: 86–7PubMed

35.

Hermesh H, Shalev A, Munitz H. Contribution of adverse drug reaction to admission rates in an acute psychiatric ward. Acta Psychiatr Scand 1985; 72: 104–10PubMedCrossRef

36.

Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Aging 1980; 9: 73–80CrossRef

37.

Popplewell PY, Henschke PJ. Acute admissions to a geriatric assessment unit. Med J Aust 1982; 1: 343–4PubMed

38.

Smucker WD, Kontak JR. Adverse drug reactions causing hospital admission in an elderly population: experience with a decision algorithm. J Am Board Fam Pract 1990; 3: 105–9PubMed

39.

Zhang M, Holman CD, Price SD, et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009; 338: 145–58CrossRef

40.

Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58: 1126–32PubMed

41.

Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15–9PubMedCrossRef

42.

Zargarzadeh AH, Emami MH, Hosseini F. Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol 2007; 34: 494–8PubMedCrossRef

43.

Waller P, Shaw M, Ho D, et al. Hospital admissions for ‘drug-induced’ disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol 2005; 59: 213–9PubMedCrossRef

44.

Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005. BMC Clin Pharmacol 2007; 7: 9PubMedCrossRef

45.

Pearson TF, Pittman DG, Longley JM, et al. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994 15; 51: 2268–72PubMed

46.

McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36: 1331–6PubMedCrossRef

47.

Bigby J, Dunn J, Goldman L, et al. Assessing the prevent-ability of emergency hospital admissions: a method for evaluating the quality of medical care in a primary care faculty. Am J Med 1987; 83: 1031–6PubMedCrossRef

48.

Grymonpre RE, Mitenko PA, Sitar DS, et al. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988; 36: 1092–8PubMed

49.

Atkin PA, Finnegan TP, Ogle SJ, et al. Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing 1994; 23: 113–6PubMedCrossRef

50.

Dartnell JGA, Anderson RP, Chohan V, et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 1634: 659–62

51.

Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54: 959–63PubMedCrossRef

52.

Green CF, Mottram DR, Rowe PH, et al. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther 2000; 25: 355–61PubMedCrossRef

53.

Wasserfallen J, Livio F, Buclin T, et al. Rate, type and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med 2001; 12: 442–7PubMedCrossRef

54.

Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199–205PubMedCrossRef

55.

Olivier P, Boublés O, Tubery M, et al. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department. Drug Saf 2002; 25: 1035–44PubMedCrossRef

56.

Howard RL, Avery AJ, Howard PD, et al. Investigation into the reasons for preventable drug-related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003; 12: 280–5PubMedCrossRef

57.

Capuano A, Motola G, Russo F, et al. Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res 2004; 50: 631–6PubMedCrossRef

58.

Juntti-Patinen L, Kuitunen T, Pere P, et al. Drug-related visits to a district hospital emergency room. Basic Clin Pharmacol Toxicol 2006; 98: 212–7PubMedCrossRef

59.

Patel KJ, Kedia MS, Bajpai D, et al. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol 2007; 7: 8PubMedCrossRef

60.

Queneau P, Bannwarth B, Carpentier F, et al. Emergency department visits caused by adverse drug events. Drug Saf 2007; 30: 81–8PubMedCrossRef

61.

Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med 2008; 19: 505–10PubMedCrossRef

62.

Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci 2008; 30: 854–62PubMedCrossRef

63.

Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008 Jun; 178: 1563–9PubMedCrossRef

64.

McKenney JM, Harrison WI. Drug-related hospital admissions. Am J Hosp Pharm 1976; 33: 792–5PubMed

65.

Ghose K. Hospital bed occupancy due to drug-related problems. J Royal Soc Med 1980; 73: 853–6

66.

Bergman U, Wiholm BE. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981; 20: 193–200PubMedCrossRef

67.

Ramsay LE, Freestone S, Silas JH. Drug-related acute medical admissions. Human Toxicol 1982; 1: 379–86CrossRef

68.

Lakshmanan MC, Hershey CO, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med 1986; 146: 1931–4PubMedCrossRef

69.

Ives TJ, Bentz EJ, Gwyther RE. Drug-related admissions to a family medicine inpatient service. Arch Intern Med 1987; 147: 1117–20PubMedCrossRef

70.

Hallas J, Harvald B, Gram LF, et al. Drug-related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83–90PubMedCrossRef

71.

Stanton LA, Peterson GM, Rumble RH, et al. Drug-related admissions to an Australian hospital. J Clin Pharm Ther 1994; 19: 341–7PubMedCrossRef

72.

Lin Wu FL, Yang CC, Shen LJ, et al. Adverse drug reactions in a medical ward. J Formos Med Assoc 1996; 95: 241–6PubMed

73.

Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996; 16: 701–7PubMed

74.

Major S, Badr S, Bahlawan L, et al. Drug-related hospitalisation at a tertiary teaching centre in Lebanon: incidence, associations, and relation to self-medicating behavior. Clin Pharmacol Ther 1998; 64: 450–61PubMedCrossRef

75.

Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33: 236–40PubMedCrossRef

76.

Jha AK, Kuperman GJ, Rittenberg E, et al. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001; 10: 113–9PubMedCrossRef

77.

Peyriere H, Cassan S, Floutard E, et al. Adverse drug events associated with hospital admission. Ann Pharmacother 2003; 37: 5–11PubMedCrossRef

78.

Dormann H, Criege-Rieck M, Neubert A, et al. Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma. Drug Saf 2003; 26: 353–62PubMedCrossRef

79.

Hardmeier B, Braunschweig S, Cavallaro M, et al. Adverse drug events caused by medication errors in medical in-patients. Swiss Med Wkly 2004; 134: 664–70PubMed

80.

Hallas J, Jensen KB, Grodum E, et al. Drug related admissions to a department of medical gastroenterology: the role of self-medicated and prescribed drugs. Scand J Gastroenterol 1991; 26: 174–80PubMedCrossRef

81.

Hallas J, Davidsen O, Grodum E, et al. Drug related illness as a cause of admission to a department of respiratory medicine. Respiration 1992; 59: 30–4PubMedCrossRef

82.

Hallas J, Gram LE, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61–8PubMedCrossRef

83.

Easton KL, Parsons BJ, Starr M, et al. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998; 169: 356–9PubMed

84.

Easton KL, Chapman CB, Brien J. Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol 2004; 57: 611–5PubMedCrossRef

85.

Stewart RB, Sprinker PK, Adams JE. Drug-related admissions to an inpatient psychiatric unit. Am J Psychiatry 1980; 137: 1093–95PubMed

86.

Salem RB, Keane TM, Williams JG. Drug-related admissions to a Veterans’ Administration psychiatric unit. Drug Intell Clin Pharm 1984; 18: 74–6PubMed

87.

Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalisations of the elderly. Arch Intern Med 1990; 150: 841–5PubMedCrossRef

88.

Wong ME, Ioannides-Demos LL, Li SC, et al. Drug-related hospital admissions of geriatric patients [abstract]. Aust J Hosp Pharm 1993; 23: 75

89.

Courtman BJ, Stallings SB. Characterization of drug-related problems in elderly patients on admission to a medical ward. Can J Hosp Pharm 1995; 48: 161–6PubMed

90.

Cunningham G, Dodd TR, Grant DJ, et al. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375–82PubMedCrossRef

91.

Malhotra S, Karan RS, Pandhi P, et al. Drug-related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703–7PubMedCrossRef

92.

Rivkin A. Admissions to a medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm 2007; 64: 1840–3PubMedCrossRef

93.

Frisk PA, Cooper JW, Campbell NA. Community-hospital pharmacist detection of drug-related problems upon patient admission to small hospitals. Am J Hosp Pharm 1977; 34: 738–42PubMed

94.

Koh Y, Kutty FB, Li SC. Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study. Pharm World Sci 2003; 25: 135–7PubMedCrossRef

95.

Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 2002; 287: 337–44PubMedCrossRef

96.

Walker J, Wynne H. Review: the frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994; 23: 255–9PubMedCrossRef

97.

Tranulis C, Skalli L, Lalonde P, et al. Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf 2008; 31: 7–20PubMedCrossRef

98.

Rittmannsberger H, Meise U, Schauflinger K, et al. Polypharmacy in psychiatric treatment: patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999; 14: 33–40PubMedCrossRef

99.

Bonati M. Epidemiological evaluation of drug use in children. J Clin Pharmacol 1994; 34: 300–5PubMedCrossRef

100.

Sturkenboom MC, Verhamme KM, Nicolosi A, et al. Drug use in children: cohort study in three European countries. BMJ 2008 Nov 24; 337: 1338–41CrossRef

101.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef

102.

Wiffen P, Gill M, Edwards J, et al. Adverse drug reactions in hospital patients. Bandolier Extra 2002: 1–15 [online]. Available from URL: http://www.medicine.ox.ac.uk/bandolier/Extraforbando/ADRPM.pdf [Accessed 2009 May 7]

103.

Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42: 1017–25PubMedCrossRef

Titel: The Relationship Between Study Characteristics and the Prevalence of Medication-Related Hospitalizations
A Literature Review and Novel Analysis
verfasst von: Anne J. Leendertse
Djurre Visser
Antoine C.G. Egberts
Dr Patricia M.L.A. van den Bemt
Publikationsdatum: 01.03.2010
Verlag: Springer International Publishing
Erschienen in: Drug Safety / Ausgabe 3/2010
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI: https://doi.org/10.2165/11319030-000000000-00000

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy

‘First, Do No Harm’: Factors that Influence Pharmacists Making Decisions about Over-the-Counter Medication

New Insights in Toxic Epidermal Necrolysis (Lyell’s Syndrome)

Prospective Drug Safety Monitoring Using the UK Primary-Care General Practice Research Database

Drug Utilization of Intrinsa® (Testosterone Patch) in England